Fundraising Fox
SERB
1 known investors
Find your way into SERB
Sign up to see every warm intro you have to SERB
- Paths you didn't know you had: your email and LinkedIn already hold routes to the SERB team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
SERB is a pharmaceutical company specializing in rare diseases and emergency medicine, with a portfolio of 70+ medicines including antidotes for chemical, biological, radiological and nuclear threats. The company serves hospitals, healthcare systems, first responders, and patients with rare conditions in oncology, neurology, and metabolic disorders across 100+ countries.
Investors · 1
Frequently asked questions
- What does SERB do?
- SERB is a pharmaceutical company specializing in rare diseases and emergency medicine, with a portfolio of 70+ medicines including antidotes for chemical, biological, radiological and nuclear threats. The company serves hospitals, healthcare systems, first responders, and patients with rare conditions in oncology, neurology, and metabolic disorders across 100+ countries.
- Who are SERB's investors?
- SERB's investors include Charterhouse Capital Partners.